
Thousands of Australians suffering from chronic kidney disease will soon get better access to a life-changing medicine that slows the progression of the silent killer.
The Pharmaceutical Benefits Scheme will be expanded on Thursday to include dapagliflozin, a drug that helps damaged kidneys function better.